HuGE Literature Finder
Records
1
-
4
The genomic landscape of low-grade serous ovarian/peritoneal carcinoma and its impact on clinical outcomes. Gynecologic oncology 2022 Jun 165 (3): 560-567. Gershenson David M, Sun Charlotte C, Westin Shannon N, Eyada Mostafa, Cobb Lauren P, Nathan Lisa C, Sood Anil K, Malpica Anais, Hillman Robert T, Wong Kwong |
Exploring the prognostic and therapeutic utility of expanded mutation profiling in appendix peritoneal metastasis managed with CRS/HIPEC. Journal of surgical oncology 2021 Mar . Zhang Chunmeng, Plambeck Benjamin D, Craig Margaret E, Tu Alexander, Mikus Ryan J, Shostrom Valerie, McDermott Sean P, Igbinigie Ikponmwosa, Brown Krista, Cushman-Vokoun Allison, Foster Jason |
Investigating the utility of extended mutation analysis in gastrointestinal peritoneal metastasis. Journal of surgical oncology 2020 Jul . Foster Jason M, Patel Asish, Zhang Chunmeng, Shostrom Valerie, Brown Krista, Cushman-Vokoun Allison |
Panitumumab and pegylated liposomal doxorubicin in platinum-resistant epithelial ovarian cancer with KRAS wild-type: the PaLiDo study, a phase II nonrandomized multicenter study. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2013 Jan 23 (1): 73-80. Steffensen Karina Dahl, Waldstrøm Marianne, Pallisgård Niels, Lund Bente, Bergfeldt Kjell, Wihl Jessica, Keldsen Nina, Marth Christian, Vergote Ignace, Jakobsen Ande |
- Page last reviewed:Jul 25, 2022
- Page last updated:Aug 16, 2022
- Content source: